Community pharmacy guide

What to do when a dispensing error has reached a patient

When a wrong medicine, strength, label, dose direction or quantity may have reached a patient, the responsible pharmacist takes control promptly, arranges clinical assessment, contacts the patient through a reliable route, checks whether other supplies are affected, records the incident, decides the external reporting routes and tests prevention.

Treat possible patient exposure as the first decision

A patient calls to say the tablets in the bag look different. A staff member finds that a label was placed on the wrong box after the patient left. A prescriber queries a dose and the team realises that the dispensed strength may have been wrong. The immediate issue is whether the person received, took or used a medicine in a way that could harm them, or has missed a medicine they needed. The responsible pharmacist should take control of the response promptly and arrange appropriate clinical assessment. A form, apology letter or root cause meeting comes later.

The NHS Specialist Pharmacy Service guidance on responding to medication incidents says that where a medication error reaches a patient, action should ensure immediate clinical safety and minimise further harm. The precise advice depends on the medicine, amount, timing, patient condition and other treatment. This article cannot tell an individual patient whether to take or stop a medicine. That instruction must come from a qualified clinician with the relevant facts and access to urgent clinical or poisons advice where needed. NHS SPS: responding to medication incidents.

Establish what was intended and what may have been supplied. Check the prescription, dispensing record, remaining stock, label, pack, barcode or image evidence where available, and the account from staff and the patient. A wrong label may be attached to the correct medicine, or a correct label to the wrong medicine. Both need a patient-specific assessment. Confirm whether the patient collected the item, whether it was delivered to a representative or care setting, and whether it may have been used. Do not downgrade the event to a near miss because the patient says they have not yet taken it unless the responsible pharmacist has verified the facts and the supply pathway.

A separate guide covers errors intercepted before supply and learning from the checking process. This page owns the different moment after supply or possible patient exposure, when patient contact and clinical safety take priority. Where a controlled-drug stock discrepancy is also present, the reconciliation and Controlled Drugs Accountable Officer route need their own review. See related guides.

Contact the patient through a reliable clinical route

The responsible pharmacist or appropriate clinician should decide the urgency, who will contact the patient, what to say and what immediate help is needed. Verify identity without revealing sensitive medicine information to the wrong person. If someone else collected the medicine, establish how to reach the patient or authorised carer. A text message or voicemail can be useful for contact, but it may be insufficient for an urgent or complex risk. Record each attempt, response, advice given, agreed next step and who remains responsible for follow-up.

Ask the patient or representative what was received and whether any doses were taken, with sensitivity and without assuming their account is wrong. A photograph of the pack may help identify it, but the clinical team should use approved secure channels. Arrange retrieval or replacement of the incorrect item only after the patient safety advice is clear. The replacement supply should be independently checked through the normal safe process. Do not let the urgency of correction lead to a second error. If the patient needs urgent medical care, the pharmacist should use the appropriate local escalation path.

If the patient cannot be reached, the responsible pharmacist should make a risk-based escalation decision. A single unanswered call is not proof that an urgent issue has been resolved. Consider known contact preferences, prescriber or care provider links, delivery records and emergency routes. The action needs to be proportionate to the potential harm and consistent with confidentiality. Document who decided the next step and when the situation will be reviewed. Avoid a blanket rule that all dispensing errors require the same number of calls or the same method.

Plan a second contact where the initial clinical assessment requires it. The patient may need to report symptoms, attend a test, collect a corrected supply or hear what the review found. Give a named contact and an agreed time or trigger for follow-up. Record whether the follow-up happened, not just that it was planned. If the patient has been referred for urgent care, establish how the pharmacy will receive or seek the outcome needed for its own safety work, subject to appropriate information sharing. The pharmacy should not repeatedly contact a patient merely to complete an internal form, but it should not abandon clinically important follow-up once the first call ends.

Check continuity of the intended treatment. A wrong supply can cause harm by adding an incorrect medicine, by omitting the prescribed medicine, or both. The clinical plan should consider whether the correct item is now available and whether the patient understands any change. If an original pack was collected by a carer, a care service or a delivery driver, confirm which person physically holds it and who can prevent further administration. A pharmacy record saying “patient informed” may conceal that the medicine remains in a household or care setting where another person could use it.

Be candid. The GPhC standards for pharmacy professionals say professionals should speak up when things go wrong, be open and honest with the person concerned, apologise, explain and put matters right where possible. The GPhC candour guidance explains the professional duty. A sincere apology is not an admission that a particular clinical outcome has been established. Do not wait for a full systems investigation before telling a patient what is known and what they need to do now. Equally, do not speculate about the cause or promise there is no risk before clinical assessment. GPhC: standards for pharmacy professionals; GPhC: keeping patients safe and being open and honest.

Check whether other supplies are affected

An error may be one basket or a wider process problem. Look at the same medicine, strength, shelf location, label template, dispensing batch, automated selection rule, delivery route and staff handover. A mixed stock shelf can affect multiple patients. A label printer or software mapping issue may repeat across many prescriptions. The responsible pharmacist and superintendent should decide how far to look back and whether other current work needs immediate checking. There is no universal seven-day or thirty-day lookback for every error.

Preserve the physical evidence. Keep the returned pack, label and relevant packaging in a secure manner according to pharmacy policy, especially if a defect or falsified product may be involved. Do not put returned medicine back into saleable stock. Record the product, strength, batch and expiry where relevant. Keep the original prescription and dispensing-system audit trail available through authorised access. If the mistake involves a system supplier or wholesaler, document when they were told and what they found. Patient data sent to third parties should be limited and governed appropriately.

If the same incorrect item went to a care home, domiciliary care provider or another healthcare setting, coordinate with the responsible clinician and the organisation that holds the medicine. A pharmacy may need to identify whether a medication administration record was changed or a dose given. The clinical care provider should make its own patient safety assessment and record care in its system. The pharmacy should not assume that sending a corrected label alone resolves the resident’s clinical risk. Document who acknowledged the message and what each organisation will do.

Review whether the error was in dispensing, prescribing, transcription, administration or communication. More than one organisation may be involved, and the answer can change as evidence emerges. Avoid using the incident category to shift blame before the patient is safe. The NHS SPS guidance recommends a compassionate, proportionate, systems-based response. The patient may need support even where another organisation originated the incorrect instruction.

Create the required incident record and decide external routes

NHS England’s community pharmacy incident reporting system guidance says English pharmacy contractors must have a patient safety incident log for all incidents. It lists information to capture where known, including incident date, people involved in dealing with it, error type, patient details, action that reduced harm and measures to prevent recurrence. The team should record the best available information promptly and update it when facts change. A record should distinguish what is known, reported by the patient and still under investigation. NHS England: community pharmacy incident reporting system.

Do not treat the internal log as every external report. The NHS England guidance for prescribing-based community pharmacy services describes use of the Learn from Patient Safety Events service for incidents meeting the national definition and local ICB reporting where a process applies. Its service context must be respected. The superintendent or contract lead should check the current national approved particulars, local ICB requirements and the service under which the medicine was supplied. Record the reporting route, decision-maker, date, reference and any follow-up requested. NHS England: prescribing-based community pharmacy incident guidance.

Consider other specific routes when facts require them. A suspected defective or falsified medicine may involve MHRA reporting or supplier action. A controlled-drug incident may involve the Controlled Drugs Accountable Officer route, and local NHS England guidance may set the process. A death or serious harm can require other patient safety and regulatory review. Whether a professional or pharmacy concern must be raised with GPhC is fact-specific. Do not put “reported” next to the incident merely because one internal form was started. Confirm each required route and its actual submission.

Professional candour and any statutory organisational duty should be assessed separately. Not every dispensing error crosses a statutory threshold, but the GPhC professional expectation to be open when things go wrong applies more broadly. The pharmacy should obtain legal or governance advice for a serious event. The patient should not be left without information while teams debate terminology. Record what was communicated, the response, apologies and agreed support in the approved clinical or incident record.

Support the people involved and learn from the process

The person who dispensed or checked the item may be distressed. Support them while gathering facts. Ask what they saw and did, how the work was organised and what conditions affected the task. The NHS SPS medication incident guidance advises timely evidence collection, chronologies, use of records and physical items, and engagement with staff and patients. It cautions against reflexively requesting formal statements as the main learning method. A psychologically safe review can reveal workload, software, storage or supervision issues that a blame-focused process misses.

Build a chronology from prescribing through selection, labelling, checking, handover, patient use and discovery. Identify each control that failed and each one that worked. Perhaps the correct medicine was selected but the wrong label attached at the final stage. Perhaps two look-alike packs shared a shelf. Perhaps the patient noticed the discrepancy before taking a dose, which reduced harm. The team should still ask why the pharmacy process did not catch it. A patient acting as the final safety barrier is not a reliable long-term control.

Choose actions against the contributing factors. Redesign a shelf, change a high-risk product alert, revise a delivery check, train staff on a new service, alter how interruptions reach the accuracy checker, or address a supplier system defect. An action should have an owner, due date and evidence of completion. “Remind the team” may be useful but is weak alone when the layout or software keeps creating the same risk. The pharmacy should check whether the change introduces a new delay or risk elsewhere.

Verify effectiveness after the fix. Sample relevant prescriptions, inspect the changed shelf after replenishment, review subsequent near misses and ask staff whether the new check is usable. If no similar errors are recorded, confirm that reporting continues rather than assuming the absence of entries proves safety. A corrective-action tracker can make this follow-up visible, but it cannot judge clinical safety or cause on its own. Share learning across branches if the process or product is common, while respecting patient privacy.

A worked example of a wrong-strength supply

A patient calls on Tuesday afternoon because the tablets in a newly collected prescription look different. The responsible pharmacist checks the record and remaining stock and sees that a higher-strength pack may have been supplied. The pharmacist arranges immediate clinical advice based on the patient’s medicine history and asks whether any doses were taken. The team contacts the prescriber where needed and records the advice and agreed monitoring in the approved clinical record. A corrected supply is prepared and checked independently. The incorrect pack is retrieved and held securely.

The superintendent is notified. The team checks other prescriptions assembled from the same temporary shelf location and finds a second bag that has not left the pharmacy. That second error is contained before supply, but the patient’s event remains a dispensing incident. The incident log records both with a clear link, not as one vague near miss. The pharmacy checks the current NHS and local reporting routes, records its submissions and communicates openly with the patient. It avoids telling the patient the error came from a look-alike pack until the review confirms that.

The review finds that the two strengths were stored together after a stock delivery and that the electronic selection screen displayed truncated names. The pharmacy changes the shelf arrangement, raises the screen issue with the supplier and adds a local verification step until the software can be improved. A later sample of dispensing work and near-miss records tests the change. This example does not prescribe clinical management of a wrong dose or a mandatory lookback period. Those require the actual medicine, patient and event facts.

FAQs

Should we tell the patient to stop or continue the medicine?

Not from this guide. Whether to take or stop a medicine must come from a qualified clinician who has the relevant facts and access to urgent clinical or poisons advice where needed. The pharmacy’s job is to arrange that assessment quickly, contact the patient through a reliable route and record the advice given. No medicine-specific dose or clinical instruction is offered here.

Is a wrong label on the correct medicine still an error that reached a patient?

Yes. A wrong label on the correct medicine and a correct label on the wrong medicine both need a patient-specific assessment. Do not downgrade the event to a near miss because the patient says they have not yet taken it, unless the responsible pharmacist has verified the facts and the supply pathway.

Does starting the internal incident log count as making the required external reports?

No. The internal patient safety incident log is separate from external routes such as the Learn from Patient Safety Events service, local ICB reporting, MHRA action on a defective or falsified medicine, the Controlled Drugs Accountable Officer route or a GPhC concern. Confirm each required route and its actual submission rather than marking the event “reported” because one internal form was started.

Can Complys decide whether the error is reportable or handle patient contact?

No. Complys can hold non-clinical action evidence such as an incident reference, the owner of a shelf or process change, a supplier response, a due date and an effectiveness review. It does not provide dispensing integration, patient contact, medicine safety judgment, candour determination or any statutory reportability decision. Those stay with the responsible pharmacist, superintendent and regulator.

Where Complys fits

Where implementation and privacy review allow, Complys can track a non-clinical incident reference, the owner of a shelf or process change, a supplier response, a due date and an effectiveness review, and hold that verified action evidence with an audit trail. It is not a dispensing system, patient record, medicines decision tool, LFPSE gateway or GPhC notifier, and it makes no dispensing integration, patient contact, medicine safety judgment, candour determination or statutory reportability decision. Keep prescription, patient contact, clinical advice and identifiable incident details in approved restricted records. The responsible pharmacist manages patient contact and required reports, and the regulator decides reportability.

Incident reporting software →More guides →